These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 36048410)

  • 21. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
    Breuer K; Werfel T; Kapp A
    Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shedding light on key pharmacological knowledge and strategies for pediatric atopic dermatitis.
    Moreno A; Renert-Yuval Y; Guttman-Yassky E
    Expert Rev Clin Pharmacol; 2023 Feb; 16(2):119-131. PubMed ID: 36705936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addressing treatment challenges in atopic dermatitis with novel topical therapies.
    Silverberg JI; Nelson DB; Yosipovitch G
    J Dermatolog Treat; 2016 Nov; 27(6):568-576. PubMed ID: 27165566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New and Upcoming Topical Treatments for Atopic Dermatitis: A Review of the Literature.
    Sideris N; Paschou E; Bakirtzi K; Kiritsi D; Papadimitriou I; Tsentemeidou A; Sotiriou E; Vakirlis E
    J Clin Med; 2022 Aug; 11(17):. PubMed ID: 36078904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing topical management of atopic dermatitis.
    Butala S; Paller AS
    Ann Allergy Asthma Immunol; 2022 May; 128(5):488-504. PubMed ID: 35288275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Non-Steroidal Topical Therapies for Inflammatory Dermatoses-Part 2: Tapinarof.
    DiRuggiero M; Mancuso-Stewart E; DiRuggiero D; Zirwas M
    Skinmed; 2023; 21(3):177-181. PubMed ID: 37634099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel treatments for pediatric atopic dermatitis.
    Scott JB; Paller AS
    Curr Opin Pediatr; 2021 Aug; 33(4):392-401. PubMed ID: 34001717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crisaborole 2% Ointment for Mild-to-Moderate Atopic Dermatitis.
    Riahi A; Lam JM
    Skin Therapy Lett; 2021 Jan; 26(1):1-4. PubMed ID: 33539061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in Current Drugs and Formulations for the Management of Atopic Dermatitis.
    Atluri K; Manne S; Nalamothu V; Mantel A; Sharma PK; Babu RJ
    Crit Rev Ther Drug Carrier Syst; 2023; 40(6):1-87. PubMed ID: 37585309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atopic Dermatitis - Current State of Research on Biological Treatment.
    Klasa B; Cichocka-Jarosz E
    J Mother Child; 2020 Jul; 24(1):53-66. PubMed ID: 33074181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on pediatric atopic dermatitis.
    Tracy A; Bhatti S; Eichenfield LF
    Cutis; 2020 Sep; 106(3):143-146. PubMed ID: 33104117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphodiesterase 4 inhibitors.
    Zebda R; Paller AS
    J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S43-S52. PubMed ID: 29248522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of topical Janus kinase and phosphodiesterase inhibitor-4 inhibitors for the treatment of atopic dermatitis: A network meta-analysis.
    Zhang L; Du D; Wang L; Guo L; Jiang X
    J Dermatol; 2021 Dec; 48(12):1877-1883. PubMed ID: 34487567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crisaborole 2% Ointment (Eucrisa) for Atopic Dermatitis.
    Woo TE; Kuzel P
    Skin Therapy Lett; 2019 Mar; 24(2):4-6. PubMed ID: 30970204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term safety and efficacy of delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with atopic dermatitis.
    Nakagawa H; Nemoto O; Igarashi A; Saeki H; Murata R; Kaino H; Nagata T
    J Dermatol; 2020 Feb; 47(2):114-120. PubMed ID: 31820485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and economics of topical calcineurin inhibitors for the treatment of atopic dermatitis.
    Abramovits W; Hung P; Tong KB
    Am J Clin Dermatol; 2006; 7(4):213-22. PubMed ID: 16901181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New treatments in atopic dermatitis.
    Puar N; Chovatiya R; Paller AS
    Ann Allergy Asthma Immunol; 2021 Jan; 126(1):21-31. PubMed ID: 32818591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs.
    Müller S; Maintz L; Bieber T
    Allergy; 2024 Jun; 79(6):1501-1515. PubMed ID: 38186219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atopic dermatitis: a review of topical nonsteroid therapy.
    Papier A; Strowd LC
    Drugs Context; 2018; 7():212521. PubMed ID: 29632548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy of atopic eczema.
    Werfel T; Claes C; Kulp W; Greiner W; von der Schulenburg JM
    GMS Health Technol Assess; 2006 Oct; 2():Doc19. PubMed ID: 21289970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.